中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
CHINESE JOURNAL OF CLINICAL HEALTHCARE
2014年
4期
380-383
,共4页
胡德喜%陆东风%林刚毅
鬍德喜%陸東風%林剛毅
호덕희%륙동풍%림강의
冠状动脉狭窄%药物洗脱支架%雷公藤内酯%基因,cdc%基质金属蛋白酶2
冠狀動脈狹窄%藥物洗脫支架%雷公籐內酯%基因,cdc%基質金屬蛋白酶2
관상동맥협착%약물세탈지가%뢰공등내지%기인,cdc%기질금속단백매2
Coronary stenosis%Drug-eluting stents%Triptolide%Genes,cdc%Matrix Metalloproteinase 2
目的:探讨雷公藤内酯醇药物洗脱支架抑制再狭窄的机制。方法18只健康国内西藏小型猪随机分为不锈钢裸支架组(BMS)、雷帕霉素洗脱支架组(SES)、雷公藤内酯醇洗脱支架(TES)100μg组,每组各6只猪,术后7 d和28 d复查冠状动脉造影后放血处死动物,分离冠状动脉支架血管段固定。测定冠状动脉外弹力膜层横断面积、支架上平均内膜厚度、支架间平均内膜厚度,观察血管平滑肌细胞的移行、增殖及内膜厚度变化,计算血管损伤积分。用免疫组织化学方法检测冠状动脉组织中基质金属蛋白酶2(MMP2)和细胞分裂周期基因2(CDC2)的蛋白表达,并进行半定量分析。结果支架植入导致的冠状动脉血管损伤积分各组均差异无统计学意义(P=0.457)。支架植入后7 d,BMS组可见增生内膜几乎全部包绕支架撑杆,SES组、TES 100μg组支架撑杆两侧可见内膜增生,管腔面支架裸露。支架植入28 d后各组血管内膜完全内皮化,BMS组支架上内膜厚度、支架间内膜膜厚度均较TES 100μg、SES组厚,差异有统计学意义( P<0.01)。支架植入后7 d和28 d,免疫组织化学分析MMP-2、CDC2激酶在BMS组中强表达,TES 100μg和SES组弱表达,平均灰度值经统计学比较,差异有统计学意义( P<0.01)。结论:雷公藤内酯醇洗脱支架100μg组剂量能很好的抑制血管内膜过度增生,预防再狭窄。
目的:探討雷公籐內酯醇藥物洗脫支架抑製再狹窄的機製。方法18隻健康國內西藏小型豬隨機分為不鏽鋼裸支架組(BMS)、雷帕黴素洗脫支架組(SES)、雷公籐內酯醇洗脫支架(TES)100μg組,每組各6隻豬,術後7 d和28 d複查冠狀動脈造影後放血處死動物,分離冠狀動脈支架血管段固定。測定冠狀動脈外彈力膜層橫斷麵積、支架上平均內膜厚度、支架間平均內膜厚度,觀察血管平滑肌細胞的移行、增殖及內膜厚度變化,計算血管損傷積分。用免疫組織化學方法檢測冠狀動脈組織中基質金屬蛋白酶2(MMP2)和細胞分裂週期基因2(CDC2)的蛋白錶達,併進行半定量分析。結果支架植入導緻的冠狀動脈血管損傷積分各組均差異無統計學意義(P=0.457)。支架植入後7 d,BMS組可見增生內膜幾乎全部包繞支架撐桿,SES組、TES 100μg組支架撐桿兩側可見內膜增生,管腔麵支架裸露。支架植入28 d後各組血管內膜完全內皮化,BMS組支架上內膜厚度、支架間內膜膜厚度均較TES 100μg、SES組厚,差異有統計學意義( P<0.01)。支架植入後7 d和28 d,免疫組織化學分析MMP-2、CDC2激酶在BMS組中彊錶達,TES 100μg和SES組弱錶達,平均灰度值經統計學比較,差異有統計學意義( P<0.01)。結論:雷公籐內酯醇洗脫支架100μg組劑量能很好的抑製血管內膜過度增生,預防再狹窄。
목적:탐토뢰공등내지순약물세탈지가억제재협착적궤제。방법18지건강국내서장소형저수궤분위불수강라지가조(BMS)、뢰파매소세탈지가조(SES)、뢰공등내지순세탈지가(TES)100μg조,매조각6지저,술후7 d화28 d복사관상동맥조영후방혈처사동물,분리관상동맥지가혈관단고정。측정관상동맥외탄력막층횡단면적、지가상평균내막후도、지가간평균내막후도,관찰혈관평활기세포적이행、증식급내막후도변화,계산혈관손상적분。용면역조직화학방법검측관상동맥조직중기질금속단백매2(MMP2)화세포분렬주기기인2(CDC2)적단백표체,병진행반정량분석。결과지가식입도치적관상동맥혈관손상적분각조균차이무통계학의의(P=0.457)。지가식입후7 d,BMS조가견증생내막궤호전부포요지가탱간,SES조、TES 100μg조지가탱간량측가견내막증생,관강면지가라로。지가식입28 d후각조혈관내막완전내피화,BMS조지가상내막후도、지가간내막막후도균교TES 100μg、SES조후,차이유통계학의의( P<0.01)。지가식입후7 d화28 d,면역조직화학분석MMP-2、CDC2격매재BMS조중강표체,TES 100μg화SES조약표체,평균회도치경통계학비교,차이유통계학의의( P<0.01)。결론:뢰공등내지순세탈지가100μg조제량능흔호적억제혈관내막과도증생,예방재협착。
Objective To reveal the mechanism of in-stent restenosis and provide theoretical fundamentals of clinical application of triptolide-eluting stent .Methods 18 tibet mini-pigs were randomly divided into 3 groups:bare metal stent group,sirolimus-eluting group and triptolide-eluting 100 μg group.At the 7th or 28th day,coronary angiography was investigated before animals were sacrificed and the coronary arteries perfusion fixed .The stented coro-nary arteries were sected and the injury score ,neointimal thickness above the struts and between the struts of stents were analyzed,The immunohistochemical staining was used to determine the protein expression of CDC 2 and MMP-2. Quantitative expression of CDC 2 and MMP-2 were analyzed by quantify the protein expression of CDC 2 and MMP-2 according to the grey of dye .Results There was no significant difference in the injury scores among the 3 groups (P=0.457)To compare the BMS group with SES、100 μg triptolide-eluting stent groups,there was a significant difference in neointimal thickness above the struts and between the struts .The complete re-endothelialization were ob-served in all groups at the 28th day.After stent implantation 7 days and 28 days, immunohistochemical analysis showed that the intensity of MMP-2 and CDC2 expressions in BMS group was higher than that in 100 μg and SES group(P<0.01).Conclusions 100 μg troptolide eluting-stent group could inhibit neointimal hyperplasia in mini-pig models .